Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 360-370

  Collette, Yves ^a,b   Chang, Hsun Lang ^c   Cerdan, Chantal ^a   Chambost, Herve ^a   Algarte, Michele ^a   Mawas, Claude ^a   Imbert, Jean ^a   Burny, Arsene ^b   Olive, Daniel ^a,d  

^a INSTITUT PAOLI CALMETTES   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c TZU CHI UNIVERSITY   (Taiwan)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; INTERLEUKIN 9; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONKEY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS GENE; VIRUS PATHOGENESIS;

BASE SEQUENCE; CELL CULTURE TECHNIQUES; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENES, NEF; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; MOLECULAR SEQUENCE DATA; TH1 CELLS; TRANSFECTION;

EID: 0030027765     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Pantaleo, G, C. Graziosi, J. F Demarest, L. Butini, M Montroni, C H Fox, J. M Orenstein, D P. Kotler, and A S Fauci. 1993 HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.
2. Embretson, J., M. Zupancic, J. L Ribas, A Burke, P. Racz, K. Tenner-Racz, and A. T. Haase 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature, 362:411.
3. Daar, E. S., T. Moudgil, R. D Meyer, and D D Ho. 1991. Transient high levels of viremia in patients with primary immunodeficiency virus type 1 infection. N Engl J Med. 324:961.
4. Clark, S. J., M. S. Saag, W. D Decker, S. Campbell-Hill, J L. Roberson, P J Veldkamp, J. C. Kappes, B.-H. Hahn, and G M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. M Engl. J. Med. 324 954.
5. Graziosi, C., G Pantaleo, L. Butini, J. F. Demarest, M. S. Saag, G. M. Shaw, and A S. Fauci. 1993 Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl. Acad. Sci. USA 90:6405.
6. Gruters, R. A, F. G. Terpstra, R. de Jong, C. J. M. Van Noesel, R. A. W Van Lier, and F. Miedema. 1990. Selective loss of T cell functions in different stages of HIV infection. Eur. J Immunol 20:1039.
7. + T cells from patients with AIDS Eur. J Immunol 17:1685
8. + T helper cell depletion occurs. J. Clin Invest. 82:1908.
9. Shearer, G. M., D C Bernstein, K. S. K. Tung, C. S. Via, R. R. Redfield, S. Z. Salahuddin, and R. C. Gallo. 1986. A model of the selective loss of major histocompatibility self restricted T cell immune responses during the development of acquired immunodeficiency syndrome (AIDS). J. Immunol. 137:2514.
10. Bentin, J., C. D. Tsoukas, J A McCutchan, S. A. Spector, D. D. Richman, and J. H Vaughan 1989. Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus. J. Clin. Immunol. 9:159.
11. Manca, F, J A. Habeshaw, and A. G Dalgleish. 1990 HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4. Lancet 335:811.
12. Viscidi, R P., K. Mayur, H. M Lederman, and A D. Frankel. 1989 Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 246:1606.
13. Skowronski, J, D Parks, and R Mariani 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12 703.
14. Lindemann, D, R. Wilhelm, P. Renard, A. Althage, R. Zinkernagel, and J. Mous 1994. Severe immunodeficiency associated with a human immunodeficiency virus type 1 NEF/3′-long terminal repeat transgene. J. Exp. Med. 179:797.
15. Brady, H. J. M., D. J Pennington, C. G Miles, and E. A. Dzierzak 1993 CD4 cell surface downregulation in HIV-1 nef transgenic mice is a consequence of intracellular sequestration. EMBO J. 12:4923
16. Kestler, H. W m. D. J. Ringler, K Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651.
17. Jamieson, B. D., G. M. Aldrovandi, V Planelles, J B. Jowett, L. Gao, L. M. Bloch, I. S. Chen, and J. A. Zack 1994. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68: 3478.
18. Robert-Guroff, M., M. Popovic, S. Gartner, P Markham, R. C Gallo, and M S. Reitz. 1990. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64:3391.
19. Franchini, G., M. Robert-Guroff, J. Ghrayeb, N. T. Chang, and F. Wong-Staal 1986 Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virology 155:593.
20. Cheng-Mayer, C., P. Iannello, K. Shaw, P. A Luciw, and J. A. Levy 1989 Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science 246:1629.
21. Maitra, R. K., N. Ahmad, S. M. Holland, and S. Venkatesan. 1991. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in nef-expressing cell lines. Virology 182:522.
22. Ahmad, N., and S. Venkatesan. 1988 Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241:1481.
23. Niederman, T M, B. J. Thielan, and L. Ratner. 1989. Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc. Natl Acad. Sci. USA 86:1128.
24. Luciw, P A., C. Cheng-Mayer, and J. A. Levy. 1987. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc. Natl Acad. Sci. USA 84:1434.
25. Bachelerie, F., J. Alcami, U Hazan, N Israel, B Goud, F. Arenzana-Seisdedos, and J. Virelizier. 1990. Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. J. Virol. 64:3059.
26. Hammes, S R., E. P. Dixon, M. H. Malim, B. R. Cullen, and W C. Greene. 1989 Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc. Natl. Acad. Sci. USA 86:9549.
27. Kim, S, K. Ikeuchi, R. Byrn, J Groopman, and D. Baltimore 1989. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl. Acad Sci USA 86:9544
28. De Ronde, A., B, Klaver, W. Keulen, L. Smit, and J. Goudsmit, 1992. Natural HIV-1 nef accelerates virus replication in primary human lymphocytes. Virology 188:391.
29. Terwilliger, E, E Langhoff, D. Gabuzda, E. Zazopoulos, and W. A. Haseltine. 1991. Allelic variations in the effects of the nef gene on replication of the human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 68:10971.
30. Spina, C. A., T. J Kwoh, M Y. Chowers, J C. Guatelli, and D. D. Richman. 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp. Med. 179 115
31. Miller, M. D, M. T. Warmerdam, I. Gaston, W. C. Greene, and M. B. Feinberg. 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp Med 179:101
32. Saksela, K, G. Cheng, and D Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14:484.
33. Yu, H., J K. Chen, S. Feng, D. C. Dalgarno, A. W Brauer, and S. L Schreiber. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933
34. Harris, M., and K. Coates. 1993. Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation. J. Gen. Virol. 74:1581.
35. Greenway, A., A. Azad, and D. McPhee. 1995. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69:1842.
36. Benichou, S., M. Bomsel, M. Bodeus, H. Durand, M Doute, F. Letourneur, J. Camonis, and R. Benarous. 1994 Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269:30073
37. Sawai, E. T., A. Baur, H. Struble, B. M. Peterlin, J. A. Levy, and C. Cheng-Mayer 1994. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci USA 91: 1539.
38. Anderson, S, D. C. Shugars, R. Swanstrom, and J V. Garcia. 1993. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 67:4923
39. Schwartz, O., Y. Riviere, J. Heard, and O. Danos 1993. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of nef. J. Virol 67:3274
40. Garcia, J. V., and A D. Miller. 1991 Serine phosphorylation-independent down-regulation of cell-surface CD4 by nef. Nature 350:508.
41. Guy, B., M. P. Kieny, Y. Rivière, C. Le Peuch, K Dott, M Girard, L. Montagnier, and J. P. Lecocq 1987 HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330:266
42. Niederman, T. M., J. V. Garcia, W R Hastings, S. Luria, and L Ratner 1992. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells J Virol. 66:6213
43. Niederman, T. M., W. R. Hastings, S. Luria, J. C. Bandres, and L. Ratner. 1993. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 194:338.
44. Baur, A. S., E. T. Sawai, P. Dazin, W. J Fantl, C. Cheng-Mayer, and B. M Peterlin 1994 HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373.
45. Luria, S., I. Chambers, and P Berg 1991. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl Acad. Sci. USA 88:5326.
46. + T cells expressing the nef protein. AIDS Res. Hum. Retroviruses 8:545.
47. + T cells. AIDS Res. Hum. Retroviruses 10:523.
48. Arya, S K., S F. Josephs, and F. Wong-Staal. 1985. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69
49. Stanley, K. K., and J. P. Luzio. 1984. Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO J. 3:1429.
50. Brack-Werner, R, A. Kleinschmidt, A. Ludvigsen, W Mellert, M. Neumann, R. Hermann, M. C L. Khim, A. Burny, N. Muller-Lantzsch, D. Stavrou, and V. Erfle 1992. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 6:273.
51. Wain-Hobson, S., P. Sonigo, O Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of AIDS virus, LAV. Cell 40:9.
52. Delassus, S, R Cheynier, and S. Wain-Hobson. 1991. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol 65:225.
53. Nunes, J., S. Klasen, M. D. Franco, C. Lipcey, C. Mawas, M. Bagnasco, and D Olive. 1993 Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochem. J. 293:835.
54. Cerdan, C, M Courcoul, D. Razanajaona, A. Pierres, M Maroc, M Lopez, P Mannoni, C. Mawas, D. Olive, and F. Birg. 1990. Activated but not resting T cells or thymocytes express colony-stimulating factor 1 mRNA without co-expressing c-fms mRNA Eur. J Immunol. 20:231.
55. Nunes, J. A, Y Collette, A. Truneh, D. Olive, and D. A. Cantrell. 1994. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J. Exp. Med. 180:1067.
56. Chambost, H, F. Brasseur, P. Coulie, E. De Plaen, A M. Stoppa, D. Baume, P. Mannoni, T. Boon, D Maraninchi, and D. Olive. 1993. A tumour-associated antigen expression in human haematological malignancies. Br. J. Haematol 84, 524.
57. Bouaboula, M., P Legoux, B. Pessegue, B. Delpech, X. Dumont, M Piechaczyk, P Casellas, and D Shire 1992. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J. Biol. Chem. 267:21830
58. LaFemina, R. L., and G S. Hayward 1986. Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells J. Virol. 58:434.
59. LaFemina, R L., and G. S. Hayward. 1988 Differences in cell-type specific blocks to immediate-early gene expression and DNA replication in human, simian, and murine cytomegalovirus. J Gen. Virol. 69:355.
60. Sambucetti, L. C., J M. Cherrington, G W. Wilkinson, and E. S Mocarski. 1989. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251.
61. Hunninghake, G. W., M. M. Monick, B Liu, and M. F. Stinski. 1989. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J. Virol. 63:3026
62. Stamminger, T., H Fickenscher, and B Fleckenstein. 1990 Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP [published erratum appears in J Gen Virol 1990 Jul, 71(Pt 7): 1627]. J. Gen. Virol. 71:105.
63. Murphy, K. M, M. J. Sweet, and D. A. Hume. 1994 The HIV-1 regulatory protein Nef has a specific function in viral expression in a murine macrophage cell line. J. Leukocyte Biol. 56: 294.
64. Gruters, R. A, S. A Otto, B. J. Al, A J. Verhoeven, C. L. Verweij, R A. Van-Lier, and F. Miedema. 1991. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription. Eur. J. Immunol. 21:167.
65. Tong-Starksen, S. E., P. A Luciw, and B. M. Peterlin. 1989. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat J. Immunol. 142:702.
66. Gaynor, R 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression AIDS 6:347 (Abstr.).
67. Fraser, J D, D. Straus, and A. Weiss. 1993. Signal transduction events leading to T-cell lymphokine gene expression. Immunol Today 14:357.
68. Penix, L, W M Weaver, Y. Pang, H. A Young, and C B. Wilson. 1993. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J Exp. Med. 178:1483
69. Szabo, S. J., J S Gold, T L Murphy, and K M. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells, roles for NF-Y and NF-ATc. Mol Cell. Biol. 13:4793.
70. Abe, E., R de Waal Malefyt, I. Matsuda, K. Arai, and N. Arai 1992. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA 89:2864.
71. Morse, H. C, S. K Chattopadhvay, M. Makino, T. N. Fredrickson, A W. Hugin, and J. W. Hartley. 1992. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607.
72. Mosier, D. E., R. A Yetter, and H C. Morse 1987. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1737.
73. Soong, L., and R. L. Tarleton. 1994. Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur. J. Immunol. 24:16.
74. Kang, S. M., B. Beverly, A Tran, K Brorson, R. H. Schwartz, and M. J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy Science 257:1134.
75. Park, D. J., H W. Rho, and S G. Rhee. 1991. CD3 stimulation causes phosphorylation of phospholipase C-τ1 on serine and tyrosine residues in a human T-cell line Proc. Natl Acad. Sci. USA 88:5453.
76. Kim, H K., J. W. Kim, A. Zilberstein, B. Margolis, J. G. Kim, J Schlessinger, and S. G. Rhee. 1991. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-τ1 phosphorylation on tyrosine residues 783 and 1254 Cell 65:435
77. Secrist, J P., L. Karnitz, and R. T. Abraham 1991. T-cell antigen receptor ligation induces tyrosine phosphorylation of phospholipase C-gammal. J. Biol. Chem. 266:12135.
78. Rincon, M., and R. A. Flawell. 1994. AP-1 transcriptional activities requires both T cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370.
79. + T cells J. Immunol. 153: 5826.
80. Graziosi, C., G. Pantaleo, K. R. Gantt, J. P. Fortin, J. F. Demarest, O. R. Cohen, R. P. Sekaly, and A. S. Fauci. 1994 Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248.
81. Maggi, E., M. Mazzetti, A Ravina, F Annunziato, M De Carli, M. P. Piccinni, R. Manetti, M. Carbonari. A. M. Pesce, G. Del Prete, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th2 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244.
82. Sher, A., R. T. Gazzinelli, I. P. Oswald, M. Clerici, M. Kullberg, E. J. Pearce, J. A. Berzofsky, T. R. Mosmann, S. L. James, and H C. Morse. 1992. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection, Immunol. Rev. 127:283.
83. + T cells. AIDS Res. Hum. Retroviruses 10:S67.
84. Clerici, M, and G. M. Shearer. 1993. A TH1→TH2 switch is a critical step in the etiology of HIV infection Immunol. Today 14:107.
85. Actor, J. K., M. Shirai, M. C Kullberg, R. M. L. Buller, A. Sher, and J. A. Berzoffsky 1993. Proc. Natl Acad. Sci. USA 90:948.
86. Khatissian, E., L. Chakrabarti, and B. Hurtrel. 1994 Cytokines patterns in lymph nodes during the early stages of simian immunodeficiency virus infection. Res. Immunol. 145:702.
87. Chakrabarti, L., M C. Cumont, L. Montagnier, and B. Hurtrel. 1995. Variable course of primary simian immunodeficiency virus infection in lymph nodes - relation to disease progression. J Virol. 68:6634.
88. Benveniste, O., B. Vaslin, R Le Grand, A Cheret, F. Matheux, F. Theodoro, P. Roques, and D. Dormont. 1995. Comparing interleukin responses during acute infection of macaques inoculated with an attenuated nef-deleted or pathogenic SICmac251. Eur. Cytokine Netw. Special Issue:C3 (Abstr.).